Citation Tools

Download PDFPDF
Clinical pharmacy and clinical trials (including case series)
Off-label use of omalizumab in cases refractory to approved treatments

Download to a citation manager

Cite this article as:
Medarde C, Fajardo CD, Lopez CF, et al
Off-label use of omalizumab in cases refractory to approved treatments